Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 31 July 2026.
Innovate UK has backed the medical device firm to advance clinical trials and research.
"We are very excited about our current progress in research and development. Validation and further development is ongoing, and we are planning our clinical trials, in collaboration with scientists from both Universities in Sheffield and internationally, in the Netherlands. We are committed to use our technology to help people that suffer from issues related to sleep."
Calculus Capital backed the e-invoicing vendor in its first investment round.
"Our investment will help CloudTrade to strengthen their global sales and support teams, expanding their platform to cover additional languages and bolstering their presence in the European and US markets. We believe this is an exciting, second phase in the development of a ‘Little British Battler’ with strong global growth potential."
Balderton Capital led the Series A round with participation from Amadeus Capital Partners and Jonathan Milner.
"Healx has a simple but profound goal: To transform the lives of rare disease patients. Our technology helps us find treatments where none currently exist,"
The Series A round was led by Legal & General with participation from ADV.
"Right now, too many people are waiting weeks or even months for care – this causes incredible stress for people and their families, and it’s also a huge expense to our health system. People deserve better than this broken status quo and we know that our technology can help."
The Yorkshire technology firm has raised seed funding from Angelfish to accelerate product development and international expansion.
"Angelfish is delighted to increase its holding in yboo and to be negotiating the potential injection of substantial funds to secure the rollout and expansion of the yboo model. In the last few months, since the initial funding, yboo has significantly advanced the technology behind the model and attract considerable trade interest within the price comparison sector."
